| Line Item | 2026-01-02 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.83B | +7.5% | +21.5% |
| Cost of Revenue | $1.65B | +3.6% | +9.0% |
| R&D Expense | $187.0M | +0.5% | +1.6% |
| SG&A Expense | $143.0M | -0.7% | +2.9% |
| Operating Income | $843.0M | +21.5% | +72.7% |
| Pre-tax Income | $707.0M | +15.1% | +102.0% |
| Income Tax | $114.0M | +75.4% | +714.3% |
| Net Income | $593.0M | +8.0% | +76.5% |
| EPS (Basic) | $2.75 | +6.6% | +74.1% |
| EPS (Diluted) | $2.60 | +7.0% | +67.7% |
| Line Item | 2026-01-02 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.05B | -5.9% | -15.5% |
| Accounts Receivable | $1.25B | +16.1% | +112.3% |
| Inventory | $1.50B | +0.1% | +1.7% |
| Current Assets | $4.21B | +4.4% | +14.9% |
| Total Assets | $8.71B | +3.2% | +9.4% |
| Current Liabilities | $3.76B | -8.6% |
| Line Item | 2026-01-02 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.25B | +135.9% | — |
| Capital Expenditures | $221.0M | +110.5% | — |
| Investing Cash Flow | -$206.0M | -128.9% | — |
| Financing Cash Flow | -$894.0M | -304.5% | — |
| Free Cash Flow | $1.03B | +142.2% | — |
| +26.7% |
| Long-term Debt | $3.50B | +0.1% | -32.7% |
| Total Liabilities | $8.25B | -3.0% | -8.7% |
| Stockholders' Equity | $459.0M | +828.6% | +142.5% |